631 related articles for article (PubMed ID: 19240171)
1. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer.
Foroulis CN; Thorpe JA
Eur J Cardiothorac Surg; 2006 Jan; 29(1):30-4. PubMed ID: 16337389
[TBL] [Abstract][Full Text] [Related]
4. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Ortner M-; Zumbusch K; Liebetruth J; Ebert B; Fleige B; Dietel M; Lochs H
Endoscopy; 2002 Aug; 34(8):611-6. PubMed ID: 12173080
[TBL] [Abstract][Full Text] [Related]
5. Porfimer sodium photodynamic therapy for management of Barrett's esophagus with high-grade dysplasia.
Panjehpour M; Overholt BF
Lasers Surg Med; 2006 Jun; 38(5):390-5. PubMed ID: 16788927
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial.
Overholt BF; Lightdale CJ; Wang KK; Canto MI; Burdick S; Haggitt RC; Bronner MP; Taylor SL; Grace MG; Depot M;
Gastrointest Endosc; 2005 Oct; 62(4):488-98. PubMed ID: 16185958
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for Barrett's esophagus: clinical update.
Overholt BF; Panjehpour M
Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
[TBL] [Abstract][Full Text] [Related]
8. The role of photodynamic therapy in the esophagus.
Gross SA; Wolfsen HC
Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):35-53, vi. PubMed ID: 19951793
[TBL] [Abstract][Full Text] [Related]
9. Long term efficacy of Photodynamic Therapy (PDT) as an ablative therapy of high grade dysplasia in Barrett's oesophagus.
Gray J; Fullarton GM
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):561-5. PubMed ID: 24284112
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy.
Davila ML
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):67-79. PubMed ID: 21112498
[TBL] [Abstract][Full Text] [Related]
11. Changes in esophageal motility after porfimer sodium photodynamic therapy for Barrett's dysplasia and mucosal carcinoma.
Shah AK; Wolfsen HC; Hemminger LL; Shah AA; DeVault KR
Dis Esophagus; 2006; 19(5):335-9. PubMed ID: 16984528
[TBL] [Abstract][Full Text] [Related]
12. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy.
Mino-Kenudson M; Ban S; Ohana M; Puricelli W; Deshpande V; Shimizu M; Nishioka NS; Lauwers GY
Am J Surg Pathol; 2007 Mar; 31(3):403-9. PubMed ID: 17325482
[TBL] [Abstract][Full Text] [Related]
13. Monte carlo model of stricture formation in photodynamic therapy of normal pig esophagus.
Jones LR; Preyer NW; Wolfsen HC; Reynolds DM; Davis MA; Wallace MB
Photochem Photobiol; 2009; 85(1):341-6. PubMed ID: 19161398
[TBL] [Abstract][Full Text] [Related]
14. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.
Oseroff AR; Blumenson LR; Wilson BD; Mang TS; Bellnier DA; Parsons JC; Frawley N; Cooper M; Zeitouni N; Dougherty TJ
Lasers Surg Med; 2006 Jun; 38(5):417-26. PubMed ID: 16788928
[TBL] [Abstract][Full Text] [Related]
15. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
16. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
[TBL] [Abstract][Full Text] [Related]
17. Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment.
Panjehpour M; Overholt BF; Phan MN; Haydek JM
Gastrointest Endosc; 2005 Jan; 61(1):13-8. PubMed ID: 15672050
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma.
Wolfsen HC; Hemminger LL; Raimondo M; Woodward TA
South Med J; 2004 Sep; 97(9):827-30. PubMed ID: 15455964
[TBL] [Abstract][Full Text] [Related]
19. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
Yachimski P; Puricelli WP; Nishioka NS
Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764
[TBL] [Abstract][Full Text] [Related]
20. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
Prasad GA; Wang KK; Buttar NS; Wongkeesong LM; Lutzke LS; Borkenhagen LS
Gastrointest Endosc; 2007 Jan; 65(1):60-6. PubMed ID: 17185080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
